FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.

EHA Library, kmira zahra, 387440

EARLY MORTALITY VARIABLES IN PATIENTS OLDER THAN 75 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Ménica Fernéndez Pérez, 387441

PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, ons charef, 387442

TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4)

EHA Library, Eliza A. Hawkes, 387443

STR-LOCI ALLELE IMBALANCE AT 9P24.1 AND PD-L1 EXPRESSION IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA.

EHA Library, Runiza Abdurashidova, 387444

MOGAMULIZUMAB IN MYCOSIS FUNGOIDES AND SÈZARY SYNDROME: AN ITALIAN SINGLE CENTER EXPERIENCE

EHA Library, Maria Pina Simula, 387445

ZUMA-24: A PHASE 2, OPEN-LABEL, MULTICENTER STUDY OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA GIVEN WITH CORTICOSTEROIDS IN THE OUTPATIENT SETTING

EHA Library, Lori Leslie, 387446

THE ROLE OF UPFRONT LENALIDOMIDE MAINTENANCE FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS RESPONDING TO FIRST-LINE MTX TREATMENT

EHA Library, Yan Zhang, 387447

OUTCOME OF VERY ELDERLY DIFFUSE LARGE B CELL LYMPHOMA, SINGLE CENTER EXPERIENCE, RETROSPECTIVE ANALYSIS

EHA Library, Jee Hyun Kong, 387448

A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES

EHA Library, Adam Olszewski, 387449

HEMATOLOGIC MALIGNANCIES AND AUTO-IMMUNITY : A CASE SERIES OF 21 PATIENTS

EHA Library, Hind Hanani, 387450

TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS

EHA Library, Yuqin Song, 387451

PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Sunil Lakhwani Lakhwani, 387452

DIFFUSE LARGE B CELL LYMPHOMA IN 65: DIAGNOSTIC, PROGNOSTIC, PROGRESSIVE AND THERAPEUTIC ASPECTS

EHA Library, Zaineb Mlayah, 387453

CORRELATION OF MYD88 AND TNFAIP3 MUTATIONS WITH CLINICO-HEMATOLOGICAL PROFILE IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, rana shaat, 387454

OUTCOMES OF PATIENTS WITH PRIMARY CNS LYMPHOMA (PCNSL) WHO UNDERWENT TREATMENT WITH  DEANGELIS, MATRIX, AND PRIMAIN PROTOCOL.: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Michelle Richardson, 387455

TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL-WORLD EXPERIENCE (ORCHID)

EHA Library, Catherine Thieblemont, 387456

PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL

EHA Library, Jake Shortt, 387457

SYNCHRONOUS SOLID TUMORS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: EXPERIENCE IN A PUBLIC HEALTHY SYSTEM IN BRAZIL.

EHA Library, Perini Guilherme, 387458

HIV-ASSOCIATED BURKITT LYMPHOMA IN THE COMBINATION ANTIRETROVIRAL THERAPY ERA: REAL-WORLD OUTCOMES AND PROGNOSTICATION

EHA Library, Chaoyu Wang, 387459

DIFFUSE LARGE B-CELL LYMPHOMA IN THE ELDERLY : RETROSPECTIVE ANALYSIS FROM A SINGLE CANCER CENTER IN ALGIERS

EHA Library, TALBI FAIZA, 387460

THE EFFECT OF BODY MASS INDEX (BMI) ON THE PROGNOSIS OF DLBCL PATIENTS TREATED WITH R-CHOP: A REAL WORLD MOROCCAN EXPERIENCE

EHA Library, Imane Ait el filali, 387461

R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA : REAL WORLD DATA

EHA Library, Maha EL AMANI, 387462

DEMOGRAPHICS, PATTERN OF CARE, AND OUTCOMES OF PRIMARY NODAL PERIPHERAL T-CELL LYMPHOMAS. DATA FROM THE MOLDOVAN HEMATOLOGICAL CENTER.

EHA Library, Victor Tomacinschii, 387463

CHILDHOOD BURKITT LYMPHOMA : ABOUT 31 CASES (EXPERIENCE OF THE PEDIATRIC CLINICAL HEMATOLOGY DEPARTMENT OF AZIZA OTHMANA'S HOSPITAL)

EHA Library, Nefzi Rihab, 387464

TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Cecilia Carmen Carpio Segura, 387465

CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMA

EHA Library, Noura Ben Yahia, 387466

THE PRE-EMPTIVE STRATEGY OF HEPATITIS B VIRAL REACTIVATION IN PATIENTS WITH MALIGNANT HEMOPATHIES RECEIVING IMMUNSUPPRESSIVE THERAPY IN TUNISIA

EHA Library, MILED Wafa, 387467

PERIPHERAL T CELL LYMPHOMA: EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS

EHA Library, Maha Charfi, 387468

EXTRANODAL NATURAL KILLER (NK)/T-CELL LYMPHOMA, NASAL-TYPE : ABOUT 11 CASES

EHA Library, Yossra AGHOUTANE, 387469

MCP-1-CCR2-M2 MACROPHAGES AXIS CONTRIBUTES TO DIFFUSE LARGE B-CELL LYMPHOMA PROGRESSION AND INHIBITS ANTITUMOR IMMUNE RESPONSE

EHA Library, Yan-Li Li, 387470

PP2A INHIBITOR LB100 ENHANCES THE SENSITIVITY OF NPM-ALK+ALCL TO CRIZOTINIB AND REVERSES THE RESISTANCE OF ALCL TO CRIZOTINIB

EHA Library, wenyu shi, 387471

A SINGLE-CELL ATLAS OF HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xiaomei Zhang, 387472

DIFFERENCES IN MUTATIONAL SIGNATURE OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE PRIMARY ORGAN

EHA Library, Hyun Hee Koh, 387473

PLTP REGULATES BCR SIGNALING AND TUMOR MICROENVIRONMENT IN DIFFUSE LARGE B-CELL LYMPHOMA THROUGH REPROGRAMMING OF LIPID METABOLISM ENVIRONMENT

EHA Library, wenyu shi, 387474

ASSAY DEVELOPMENT AND VALIDATION OF IG-HTS TO MONITOR MRD IN PLASMA OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Jinghua Wu, 387475

PREDICTING CELL OF ORIGIN FROM DIGITIZED IMAGES OF HEMATOXYLIN AND EOSIN-STAINED SLIDES OF DIFFUSE LARGE B-CELL LYMPHOMAS USING A CELL-BASED DEEP-LEARNING MODEL

EHA Library, Camille Laurent, 387476

COMPREHENSIVE ANALYSIS OF P53-RESPONSIVE MIRNA’S GENES METHYLATION, TP53 GENE MUTATIONS AND POLYADENYLATION SIGNAL DESTRUCTION IN DIFFUSE LARGE B-CELL LYMPHOMA TUMOR TISSUE.

EHA Library, Elena Voropaeva, 387477

SPECIFIC ALTERATIONS IN MEMBRANE LIPID LEVELS AS POTENTIAL BIOMARKERS IN DLBCL PATIENTS

EHA Library, Federica Loscocco, 387478

DEVELOPING GENOMIC TESTS THAT GUIDE LARGE B-CELL LYMPHOMA DIAGNOSIS AND TREATMENT: LYMPH2CX AND LYMPH3CX ASSAYS

EHA Library, Ryan S. Robetorye, 387479

EFFICACY ANALYSIS OF BRUTON'S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, wenyu shi, 387480

EFFECTS OF ANTIFASCIN COMPOUNDS AGAINST LYMPHOMA CELLS IN VITRO

EHA Library, Ana María Hurtado López, 387481

MICROSATELLITE INSTABILITY AND 9P24.1 ALTERATIONS IN HODGKIN LYMPHOMA

EHA Library, Ekaterina Tregubova, 387482

EVALUATION OF NEW MACHINE LEARNING SYSTEMS FOR PROGNOSTICATION BASED ON GENE EXPRESSION SIGNATURES IN MANTLE CELL AND PERIPHERAL T CELL LYMPHOMAS

EHA Library, Adrian Mosquera-Orgueira, 387483

CINOBUFAGIN PROMOTES APOPTOSIS OF DIFFUSE LARGE B LYMPHOMA CELLS BY INHIBITING UBIQUITINATION DEGRADATION OF TP53

EHA Library, Sanxiu He, 387484

ASSESSMENT OF NANOPORE LONG-READ WHOLE-GENOME SEQUENCING FOR THE DETECTION OF LARGE CHROMOSOMAL STRUCTURAL VARIANTS IN MANTLE CELL LYMPHOMA

EHA Library, Marcus Hansen, 387485

ALTERATIONS OF THE GUT MICROBIOTA AS A NON-INVASIVE DIAGNOSTIC BIOMARKER FOR NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, Zhuangzhuang Shi, 387486

DIAGNOSTIC SIGNIFICANCE OF CYTOKINE EXPRESSION LEVELS IN CEREBROSPINAL FLUID FOR CENTRAL NERVOUS SYSTEM INFILTRATION OF LYMPHOMA

EHA Library, Luo Xin, 387487

STUDY OF GENETIC ALTERATIONS USING A CUSTOM LYMPHOID TARGETED NGS PANEL IN PATIENTS WITH FOLLICULAR LYMPHOMA: A PILOT STUDY

EHA Library, Evgenii Kunevich, 387488

FREQUENCY OF IKZF3 MUTATION IN WALDENSTRÖM'S MACROGLOBULINEMIA

EHA Library, Assia Taleb, 387489

MRNA IDENTIFICATION OF TIGIT IN PERITUMORAL LYMPHOCYTES IN CLASSICAL HODGKIN DISEASE

EHA Library, Ombretta Annibali, 387490

ACTIVATION OF ER STRESS AND UNFOLDED PROTEIN RESPONSE (UPR) PATHWAYS IN HEPATITIS B VIRUS (HBV) INFECTED B CELLS AND ITS SIGNIFICANCE IN PATHOGENESIS OF B-CELL NON-HODGKIN LYMPHOMAS (B-NHL)

EHA Library, Mihaela Uta, 387491

PTPRJ AS A ROBUST DIFFERENTIATING MARKER IN MANTLE CELL LYMPHOMA

EHA Library, Simone Valentin Hansen, 387492

ASSOCIATIONS BETWEEN GLYCOLYSIS PATTERNS AND IMMUNE CELL INFILTRATION IN THE TUMOR MICROENVIRONMENT IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS

EHA Library, Peipei Xu, 387493

HDACI COMBINED WITH LB100 PROMOTES THE OCCURRENCE OF FERROZOSIS IN CTCL

EHA Library, wenyu shi, 387494

TRANSCRIPTOME ANALYSIS OF DIFFUSE LARGE B-CELL LYMPHOMA CELLS EXPRESSING MYD88 L265P REVEALS CD44, LGALS3, NFKBIZ AND BATF AS DOWNSTREAM TARGETS OF ONCOGENIC NF-ΚB SIGNALING.

EHA Library, Marcello Turi, 387495

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA IN 2 CENTERS OF BOGOTÁ – COLOMBIA: THE LARGEST CASE SERIES IN LATIN AMERICA

EHA Library, Maria Cynthia Fuentes Lacouture, 387496

BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY

EHA Library, Xudong Zhang, 387497

THE EFFECT OF BONE MARROW CD4/CD8+ RATIO ON RESPONSE TO TREATMENT AND SURVIVAL IN LYMPHOMAS

EHA Library, Istemi Serin, 387498

DETERMINING MOLECULAR BACKGROUND OF A GROUP OF CHILDHOOD LEUKEMIA/LYMPHOMA PATIENTS WITH POSITIVE FAMILY HISTORY FROM TÜRKIYE

EHA Library, Ozden Hatırnaz Ng, 387499

CLINICAL CHARACTERISTICSAND PROGNOSIS RISK FACTORS OF NON-HODGKIN'S LYMPHOMA INVOLVING THE HEART

EHA Library, Peipei Xu, 387500

THE FREQUENCY OF L265P MUTATION IN MYD88 GENE AT DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Anastasiya Dubrovina, 387501

ASSOCIATION OF P14ARF EXPRESSION WITH THE RISK OF PROGRESSION AND DEATH IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Maria Sarpova, 387502

BAICALIN MODULATES INTESTINAL FLORA TO TREAT AGVHD

EHA Library, Xing Cui, 387503

EFFECT OF PINK NOISE ON IMPROVING SLEEP QUALITY OF PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Zhenglan He, 387504

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) WITH CYCLOPHOSPHAMIDE IN PEDIATRIC HIGH-RISK ACUTE MYELOID LEUKEMIA (HR-AML)

EHA Library, Ming Sun, 387505

PREVALENCE OF METABOLIC SYNDROME IN LONG TERM HEMATOPOIETIC STEM CELL TRANSPLANTATION SURVIVORS: COMPARISON WITH A MATCHED REFERENCE COHORT.

EHA Library, Nicole van Yperen, 387506

CLINICAL PROGNOSTIC MODEL OF LIVER FAILURE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Qingyuan Qu, 387507

THE EFFICACY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR AUTOLOGOUS-HSCT IN LOW-RISK AND INTERMEDIATE-RISK AML PATIENTS

EHA Library, Erlie Jiang, 387509

OUTCOMES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS–SINGLE CENTRE EXPERIENCE FROM PAKISTAN

EHA Library, mussawair hussain, 387510

SALVAGE THERAPY WITH VENETOCLAX AND A HYPOMETHYLATING AGENT FOR PATIENTS WITH AML RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Inna Shaforostova, 387511

TOTAL BODY IRRADIATION VERSUS NON TOTAL BODY IRRADIATION CONTAINING REGIMENS FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sabrine Mekni, 387512

THE ROLE OF NUTRITIONAL SUPPORT DURING AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN LYMPHOMA.

EHA Library, Stanislav Volchenkov, 387513

EFFICACY AND SAFETY OF BIOSIMILAR PEGFILGRASTIM AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A COMPARATIVE STUDY WITH BIOSIMILAR FILGRASTIM, LENOGRASTIM AND ORIGINATOR PEGFILGRASTIM

EHA Library, Francesco MARCHESI, 387514

PRESENCE´S IMPACT OF NON-SPECIFIC ANTI-HLA ANTIBODIES ON THE DEVELOPMENT OF PRIMARY GRAFT FAILURE IN PATIENTS UNDERGOING PERIPHERAL BLOOD HAPLOIDENTICAL HSCT, EXPERIENCE AT A CENTER IN MEXICO.

EHA Library, Juan Daniel Garza Escobar, 387515

CLINICAL FEATURES AND PROGNOSIS OF ADENOVIRUS INFECTION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Wei SUN, 387516

THE OUTCOME OF VIRAL HEPATITIS-C INFECTION ON HEMATOLOGICAL MALIGNANCIES AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION IN EGYPT

EHA Library, Salma Elashwah, 387517

DEVELOPMENT AND VALIDATION OF THE PRACT MODEL FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS ABOVE 60 YEARS OLD WITH HAEMATOLOGICAL MALIGNANCIES IN A REAL-WORLD STUDY

EHA Library, Jing Liu, 387518

EPSTEIN-BARR VIRUS-ASSOCIATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE : RESULTS OF A DELPHI STUDY IN SPAIN.

EHA Library, Anna Sureda, 387519

PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED

EHA Library, Takafumi Tsushima, 387520

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIOR INFECTION CAUSED BY THE SARS-COV-2 (COVID-19)

EHA Library, Aleksandr Siniaev, 387521

ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.

EHA Library, RIMMEL YOSRA KANOUN, 387522

EFFICACY AND SAFETY OF COMBINED THERAPY OF RECOMBINANT HUMAN THROMBOPOIETIN AND ELTROMBOPAG FOR TREATMENT OF PERSISTENT THROMBOCYTOPENIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Pan pan, 387523

SORAFENIB MAINTENANCE TAILORED TO FLT3-MUTATED AML AFTER ALLOGENEIC HCT IS HIGHLY FEASIBLE AND EFFECTIVE: A REAL-LIFE EXPERIENCE

EHA Library, Elisa Diral, 387524

THE RISK FACTORS ON THE SEVERITY OF SARS-COV2 OMICRON VARIANT INFECTION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIEITC STEM CELL TRANSPLANTATION

EHA Library, Zhihui Li, 387525

CLINICAL EFFICACY AND HEALTH-RELATED QUALITY OF LIFE IN SEVERE APLASTIC ANEMIA TREATED BY UMBILICAL CORD BLOOD TRANSPLANTATION: A CROSS-SECTIONAL SURVEY IN CHINA

EHA Library, Ping Li, 387526

A PROGNOSTIC MODEL FOR EPILEPTIC SEIZURES IN PATIENTS FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY

EHA Library, Yin Zhu, 387527

EVALUATION OF OUTCOME AND SAFETY PROFILE IN HIGH-DOSE BEAM AND BEEAM CHEMOTHERAPY WITH SUBSEQUENT AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS – SINGLE-CENTER EXPERIENCE

EHA Library, Kinga Krawiec, 387528

OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA IN PEDIATRIC POPULATION - A SINGLE CENTER EXPERIENCE FROM PUBLIC HOSPITAL

EHA Library, RAJESH PATIL, 387529

MULTIPLE MYELOMA TRANSPLANT DATABASE IN PATIENTS OVER THE AGE OF 65: A SINGLE CENTRE RETROSPECTIVE COHORT ANALYSIS

EHA Library, Janet Tan, 387530

APPLICATION GENE VARIATION DETECTION BEFORE AND AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION TO PREDICT THE RELAPSE OF PATIENTS AFTER TRANSPLANTATION: RETROSPECTIVE DATA FROM A SINGLE CENTER IN CHINA

EHA Library, Jia Liu, 387531

DONOR CELL INDUCING IMMUNE-TOLERANCE IMPROVED ENGRAFTMENT IN TΑΒ+ CELL DEPLETED HSCT IN PATIENTS WITH THALASSEMIA MAJOR

EHA Library, Chunfu Li, 387532

ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOMES IN HODGKIN LYMPHOMA: A PROGNOSTIC STUDY OF 30 PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

EHA Library, Shayan Zamani, 387533

EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Shayan Zamani, 387534

ASSOCIATION OF WILMS TUMOR GENE 1 EXPRESSION WITH OVERALL SURVIVAL AFTER AZACYTIDINE AND DONOR LYMPHOCYTE INFUSIONS: A RETROSPECTIVE SINGLE CENTER ANALYSIS

EHA Library, Semra Aydin, 387535

EARLIER ENGRAFTMENT WITHOUT INCREASE OF GVHD IN HIGHER DOSE OF CD34+ CELLS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Tran-Der Tan, 387536

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LYMPHOMA: A 10-YEAR REVIEW OF ACTIVITY AT THE TUNISIAN NATIONAL BONE MARROW TRANSPLANTATION CENTER

EHA Library, Insaf Ben yaiche, 387537

CD34+ CELL DOSE EFFECTS ON CLINICAL OUTCOMES OF ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)

EHA Library, Min Xiong, 387538

BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Antonella Mancusi, 387539

APPLICABILITY OF SHORT TANDEM REPEAT (STR) IN LEUKEMIA PATIENTS RECEIVED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE ERA OF MINIMAL RESIDUAL DISEASE (MRD)

EHA Library, JUHYUNG KIM, 387540